Nivolumab Enhances In Vitro Effector Functions of PD-1+ T-Lymphocytes and Leishmania-Infected Human Myeloid Cells in a Host Cell-Dependent Manner.

Filippis, Christodoulos; Arens, Katharina; Noubissi Nzeteu, Gaetan Aime; Reichmann, Gabriele; Waibler, Zoe; Crauwels, Peter; van Zandbergen, Ger

Nivolumab Enhances In Vitro Effector Functions of PD-1⁺ T-Lymphocytes and Leishmania-Infected Human Myeloid Cells in a Host Cell-Dependent Manner.

Filippis, Christodoulos; Arens, Katharina; Noubissi Nzeteu, Gaetan Aime; Reichmann, Gabriele; Waibler, Zoe; Crauwels, Peter; van Zandbergen, Ger.

Afiliação

Filippis C; Division of Immunology, Paul-Ehrlich-Institut, Langen, Germany.
Arens K; Division of Immunology, Paul-Ehrlich-Institut, Langen, Germany.
Noubissi Nzeteu GA; Division of Immunology, Paul-Ehrlich-Institut, Langen, Germany.
Reichmann G; Division of Immunology, Paul-Ehrlich-Institut, Langen, Germany.
Waibler Z; Division of Immunology, Paul-Ehrlich-Institut, Langen, Germany.
Crauwels P; Division of Immunology, Paul-Ehrlich-Institut, Langen, Germany.
van Zandbergen G; Division of Immunology, Paul-Ehrlich-Institut, Langen, Germany.

Front Immunol ; 8: 1880, 2017.

Article em En | MEDLINE | ID: mdl-29312350

Palavras-chave

Leishmania; T-cells; human dendritic cells; human macrophages; nivolumab; programmed death-1; programmed death-1 ligand 1; programmed death-1 ligand 2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article